These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Somatic mutations in Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407 [TBL] [Abstract][Full Text] [Related]
25. Pediatric oral Epstein-Barr virus associated self-remitting CD30+ lymphoproliferative disorder: A distinct entity. Schwartz Z; Bowe RB; Coleman M; Magro CM Ann Diagn Pathol; 2018 Dec; 37():57-61. PubMed ID: 30292067 [TBL] [Abstract][Full Text] [Related]
26. When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders. Sacco KA; Notarangelo LD; Delmonte OM Clin Microbiol Infect; 2023 Apr; 29(4):457-462. PubMed ID: 36209991 [TBL] [Abstract][Full Text] [Related]
27. Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop. Climent F; Nicolae A; de Leval L; Dirnhofer S; Leoncini L; Ondrejka SL; Soma L; Wotherspoon A; Zamo A; Quintanilla-Martinez L; Ng SB Virchows Arch; 2023 Sep; 483(3):333-348. PubMed ID: 37646869 [TBL] [Abstract][Full Text] [Related]
28. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis. Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602 [TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach. Hue SS; Oon ML; Wang S; Tan SY; Ng SB Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131 [TBL] [Abstract][Full Text] [Related]
30. Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders. Kakiuchi S; Yakushijin K; Takagi I; Rikitake J; Akiyama H; Matsuba H; Hayashi Y; Kajimoto K; Iwata N Front Med (Lausanne); 2020; 7():625442. PubMed ID: 33425968 [TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting. Cohen JI; Iwatsuki K; Ko YH; Kimura H; Manoli I; Ohshima K; Pittaluga S; Quintanilla-Martinez L; Jaffe ES Leuk Lymphoma; 2020 Apr; 61(4):808-819. PubMed ID: 31833428 [TBL] [Abstract][Full Text] [Related]
32. Inherited Genetic Susceptibility to Nonimmunosuppressed Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases in Chinese Patients. Guan YQ; Shen KF; Yang L; Cai HD; Zhang ML; Wang JC; Long XL; Xiong J; Gu J; Zhang PL; Xiao M; Zhang W; Zhou JF Curr Med Sci; 2021 Jun; 41(3):482-490. PubMed ID: 34170459 [TBL] [Abstract][Full Text] [Related]
33. How I Diagnose EBV-Positive B- and T-Cell Lymphoproliferative Disorders. Dojcinov SD; Quintanilla-Martinez L Am J Clin Pathol; 2023 Jan; 159(1):14-33. PubMed ID: 36214507 [TBL] [Abstract][Full Text] [Related]
34. Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology. Attygalle AD; Cabeçadas J; Gaulard P; Jaffe ES; de Jong D; Ko YH; Said J; Klapper W Histopathology; 2014 Jan; 64(2):171-99. PubMed ID: 24128129 [TBL] [Abstract][Full Text] [Related]
35. Study of association of Epstein-Barr virus in lymphomas by Epstein-Barr virus-encoded RNA Gala R; Gandhi JS; Gupta G; Grover SK; Sharma A; Pasricha S; Mehta A Indian J Pathol Microbiol; 2017; 60(3):341-349. PubMed ID: 28937369 [TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Cohen JI; Kimura H; Nakamura S; Ko YH; Jaffe ES Ann Oncol; 2009 Sep; 20(9):1472-1482. PubMed ID: 19515747 [TBL] [Abstract][Full Text] [Related]
38. The superiority of Epstein-Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV-positive NK-cell lymphoproliferative diseases. Zheng M; Bao Y; Wang J; Ma Y; Yang Y; Zhang P; Chen L; Zheng K; Zhou J Hematol Oncol; 2022 Aug; 40(3):381-389. PubMed ID: 35405763 [TBL] [Abstract][Full Text] [Related]
39. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder]. Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294 [TBL] [Abstract][Full Text] [Related]
40. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases. Qin C; Huang Y; Feng Y; Li M; Guo N; Rao H Diagn Pathol; 2018 Feb; 13(1):17. PubMed ID: 29482573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]